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Abstract
The appearance of sideroblasts in hypoplastic anemia (HAl and acute myelocytic leukemia
(AML), together with their sideroblastograms, was studied. Hematological studies on cases with
type III sideroblast dominance by sideroblastograms produced the following results. Type III
sideroblast dominant HA was observed in three of 63 cases. Two of the above three cases had
what we call “atypical factor”, while the remaining one became AML in its clinical course and
could be considered to be leukemia in a hypoplastic preleukemic stage. Type III sideroblast dom-
inant AML was noted in five of 32 cases. Three of these five cases are compatible with low
percentage leukemia, and one of the above three cases showed ringed sideroblasts exhibiting ery-
throleukemia in the terminal stage. In HA and AML, type III sideroblast dominant cases have to
be examined in relation to atypical HA and atypical leukemia. Changes of iron meta. bolism in
erythroblasts with preleukemic stage will be attributable to disturbance of erythropoiesis such as
erythroid hyperplasia in bone marrow and also, in part, to disturbance of hemoglobin synthesis.
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Abstract: The appearance of sideroblasts in hypoplastic anemia
(HAl and acute myelocytic leukemia (AML), together with their sidero-
blastograms, was studied. Hematological studies on cases with type
III sideroblast dominance by sideroblastograms produced the following
results. Type III sideroblast dominant HA was observed in three of
63 cases. Two of the above three cases had what we call "atypical
factor", while the remaining one became AML in its clinical course
and could be considered to be leukemia in a hypoplastic preleukemic
stage. Type III sideroblast dominant AML was noted in five of 32
cases. Three of these five cases are compatible with low percentage
leukemia, and one of the above three cases showed ringed sidero-
blasts exhibiting erythroleukemia in the terminal stage. In HA and
AML, type III sideroblast dominant cases have to be examined in
relation to atypical HA and atypical leukemia. Changes of iron meta.
bolism in erythroblasts with preleukemic stage will be attributable to
disturbance of erythropoiesis such as erythroid hyperplasia in bone
marrow and also, in part, to disturbance of hemoglobin synthesis.
Close clinical examination of cases with apparent hypoplastic anemia
(HA) has often proved to be paroxysmal nocturnal hemoglobinuria (PNH) (l)
or, in the clinical course, to be leukemia. We have already reported several
cases each of the above types (2). On the other hand, in our daily clinical
practice it is sometimes found (3), though rarely, that in the category of leuke-
mia, there are cases wherein differential diagnosis is required between atypical
leukemia, hypoplastic leukemia and low percentage leukemia with the bone
marrow showing remarkable hypoplasia and with the blast count so low as
similar to that observed in HA.
The clinical picture of HA is characterized by peripheral pancytopenia and
hematopoietic disturbance in bone marrow. Its diagnosis seems to be rather
easy based on hematological findings, tissue culture on the bone marrow, the
sideroblastogram, and serum Fe and Cu levels. As mentioned, however, HA
occasionally turns out to be PNH or leukemia. Thus, the possibility cannot
be ruled out that one often includes some other diseases in so-called HA.
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From hematological findings, we have already instituted atypical HA.
lf HA should include other diseases, it is necessary to watch for atypical HA
and to study it not only in terms of peripheral bood, myelograms and serum
Fe and Cu levels but also from various other aspects, so as to identify more
atypical factors than those currently known.
From the above point of view, we have studied the incidence of siderobasts
and the sideroblastogram in HA, and have also carried out similar studies on
acute myelocytic leukemia (AML).
MATERIALS AND METHODS
1) Subjects:
Involved in our present studies were 63 cases of idiopathic HA and 32 cases
of AML who were admitted to our department during the period from 1952 to
1972 and were examined for sideroblasts. None of these cases had been treated
previously. The cases whose clinical picture and examinations indicated evi-
dent complication by infections or hepato-renal damage were excluded from
the studies. Thirty-eight normal subjects were employed as a control group.
2) Methods:
The method employed for sideroblasts was almost the same as that de-
scribed by KAPLAN (4). The classification of sideroblasts and the preparation of
the sideroblastogram were made according to our methods (5) (Fig. 1). Our
studies emphasized the appearance of sideroblasts and the sideroblastogram in
the subjects; in particular, the cases dominated by the type III sideroblast
were statistically extracted and their hematological features were examined.
No. of granules 0 1"'2 3 ""5 6'" incomplete complete
Ringed Ringed
Type 0 IT ill ( TV) (V)
Fig. 1. Classification of sideroblast (KIMURA 1955)
RESULTS
1) Sideroblast appearance in H A and AML :
The appea.rance of sideroblasts in HA and AML is presented in the figure;
30.6±8.2% in the control group, 85.3±ll.O% in HA, and 67.8±24. 7%
in AML, indicating a high incidence in HA and AML. Especially in HA
statistics showed a low variance, which appeared to be characteristic. The
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appearance of sideroblasts in monocytic leukemia (MoL) was 70. 0 ± 24. 1%
(Fig. 2).
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Fig. 2. Incidences of siderob1ast
2) Examinations of the sideroblatogram in H A and AML :
The pattern of appearance in normal subjects was found to be, as pre-
sented in the figure, type 0: 69.4±8.2%, type I: 26.4±7. 7%, type II:
4. 9±2. 8%, type III: 0.8% or less; with statistically significant differences
% %
100 100
o
.<; 0 IT III Type
Fig. 3. Sideroblastogram in control,
type 0; 69. 4±8. 2%, type I; 26. 4± 7.7%,
type I; 4.9±2.8%, type m ~0.8%
o IT III Type
Fig.4. Sideroblastogram in hypoplastic
anemia, type 0; 14. 7± 11.0%, type I ;
22.5±7.3%, type!; 45.0±9. 7%, type m
17.7±10.9%
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between the types, the sideroblastogram showed a decreasing pattern from type
o to type III, as a characteristic finding (Fig. 3).
For HA, as shown in the figure, the results were type 0: 14.7 ± 11.0%,
type I: 22. 5± 7.3%, type II: 45. 0±9. 7%, and type III: 17. 7± 10.9%,
confirming a characteristic pattern of type II sideroblast dominance reported
previously (5). The incidence of type II siderobalst dominant cases was very
high, being 54 (86.6%) of 63 cases (Fig. 4).
On the other hand, the sideroblastogram in AML was not statistically
significant; type 0: 32.2±24.7%, type I: 21.6±8.3%, type II: 31.1 ± 16.8%,
and type III: 20. O± 17. 6%. Type III sideroblast dominance was noted in
5 (15.6%) of 32 cases (Fig. 5). In one (Case 5) of five cases, ringed sidero-
blasts were present up to 8%.
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Fig. 5. Siderob1astogram in AML, type 0; 32. 2±24. 7%,
type I ; 21. 6±8. 3%, type I; 31.1 ± 16. 8%, type BI 20. O± 17. 6%
3) Hematological findings in type I I I sideroblast dominant H A:
The hematological findings in three cases exhibiting type III sideroblast
dominance are summarized in the Table. At the time of admission, one case
showed reticulocytosis and two cases erythroid hyperplasia in bone marrow.
On admission, Case 3 was complicated by an atypical factor, i. e. a shift to
the left in the granulocytic series and became AML (Table 1).
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TABLE 1 HEMATOLOGICAL FINDINGS OF TYPE III SIDEROBLAST DOMINANT**
CASES IN HYPOPLASTIC ANEMIA
177
No of Peripheral Blood Bone Marrow My-Bl. Type III
Case Age Sex WBC RBC Thr. Retic. NCC Ery·Bl. Siderobl.
(x103 ) (x104 ) (x 104 ) (%0) (x 104 ) (%) (%) (%)
1. 60 F 5.4 266 10.6 ? ? 20.4 0.8 36.0
2. 12 M 3.1 251 1.5 24.0 23. 7 52.8 0.4 52.0
3.* 55 M 1.5 198 3.8 9.0 11. 0 31.8 1.4 40.0
* Left shift of granulocyte series( +), terminated in AML
.* 3 of 63 cases, 4.1%
4) Hematoogical findings of type III sideroblast dominant AML:
Hematological findings in five cases of AML exhibiting type III sidero-
blast dominance in the sideroblastogram are presented in the Table. Low
levels of blasts in the peripheral blood and bone marrow, :i. e., identical
findings to those in low percentage leukemia, were observed in three cases.
The Case 5 was, on admission, considered to belong to the preleukemic stage
exhibiting incompletely ringed sideroblasts, and within a few months proved
to be low percentage leukemia. About six months later, this case showed
erythroid hyperplasia, atypical erythroblasts, PAS-positivity and hiatus ery-
throleukemia (Table 2).
TABLE 2 HEMATOLOGICAL FINDINGS OF TYPE III SIDEROBLAST DOMINANT***
CASES IN ACUTE MYELOCYTIC LEUKEMIA
No of Peripheral Blood Bone Marrow
Case Age Sex WBC Blast
(x 103 ) (%) NCC(x104) Blast(%) Erythr. (%) Type III Siderobl. (%)
1* 67 M 4.3 13 ? 14.8 49.6 71
2 57 M 10. 7 6 30.3 6.4 25.6 62
3 30 M 88.0 64.0 15.4 68.2 1.6 48
4 39 M 18.3 32.0 67.5 36.2 2.0 70
5* ** 34 M 2.8 0 8.6 5.8 29.4 51,
* Megaloblastoid cell( +)
** Ringed sideroblast(+ ), terminated in erythroleukemia
*** 5 of 32 cases, 15.6%
tOo % Ringed r. Ringel:! % Ringed::;":: l ='~: l :~' 'g
"L LA 1)\<.
o 0 1 n m w V- 0 I n m 'R V 0 I n m 11 V
Low percentage leukemia - Erythroleukemia
Fig. 6. Changes in the sideroblastogram of Case 5
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DISCUSSION
Sideroblast is defined as an erythroblast containing stainable iron granules.
These granules are known to be non-hemin iron along the iron metabolism of
erythroblasts (4). The iron absorbed from the intestinal mucosa is directly
used for hematopoiesis and, at the same time, it is stored in the organs as
ferritin and hemosiderin, which, when needed, are mobilized to erythroblasts
in bone marrow for heme synthesis. In iron metabolism, the erythroblasts
play an important role in the course of change from non-hemin iron to hemin
iron. Sideroblasts may be considered important for investigating the actual
state of iron metabolism. Thus far, numerous reports have been published on
sideroblasts; systematic studies on sideroblasts in blood diseases have already
been reported by the authors (5).
Numerous reports have been published on PNH, leukemia with a hypo-
plastic preleukemic stage, hypoplastic leukemia and low percentage leukemia,
which should be differentiated from HA; and differentiation of HA, its ana-
logous diseases and leukemia are clinically interesting problems (6). In our
studies of leukemia with a hypoplastic preleukemic stage, we have already
instituted as atypical HA group. Among cases of atypical HA, those that
showed the presence of atypical factors, i. e. erythroblasts in the peripheral
blood, erythroid hyperplasia in bone marrow, mild increase of blasts in bone
marrow or a shift to the left of the granulocytes, were classified as leukemia
in a hypoplastic preleukemic stage. If HA should include not only leukemia
but also other diseases, this atypical HA group should draw attention (2).
We have re-examined the sideroblasts in HA and AML, and studied the
question as to whether or not type III sideroblast dominant cases on the sidero-
blastogram can be clinically regarded as atypical cases. The incidence of
siderobalsts in HA and AML was 85. 3± 11. 0% and 67. 8±24. 7%, respec-
tively, while it was 30.6 ± 8. 2% in the control group. Sideroblasts are found
during the dynamic course of hemoglobin synthesis from non-hemin iron (7),
and the appearance of sideroblasts is influenced by serum iron, i. e., by the
supply of iron from the serum and by hematopoietic function. In HA and AML
whereby erythropoietic function is low, the high appearance of sideroblasts can
be easily explained. In AML, the appea~ance of sideroblasts is higher than
in the control group, but is less uniform and shows a greater statistical variance
than in HA. This is believed to occur since the erythropoietic damage in
in AML is mainly due to displacement of granulocytes by tumorous prolifera-
tion, the incidence of granulocyte is not uniform, and latent hemorrhage and
infection are more frequent.
Our study on sideroblastograms has confirmed that type II sideroblast
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dominance in HA is a characteristic pattern (5). On the other hand, the
incidence of type III sideroblast dominant cases was very low, being only
three (4. 1%) of 63 cases. The question is as to whether or not such cases can
be regarded as atypical. Examination of the blood picture on admission
showed, as already mentioned, the presence of reticulocytosis, erythroid hy-
perplasia in bone marrow and a shift to the left in the granulocytic series,
indicating hematologically atypical factors. Especially noteworthy is that one
of three cases became AML during its clinical course; retrospectively, this
case was leukemia with a hypoplastic preleukemic stage. From this finding,
cases among HA with type III sideroblast dominance on the sideroblastogram
will require clinical follow-up and pathologic analysis as cases of atypical
HA. Examining 53 cases exhibiting a preleukemic state, we reported that
many of these c~ses showed erythrobalstic damage as seen in HA (frequent
incidence of erythroid hyperplasia in bone marrow), pernicious anemia and
sideroblastic anemia (3). Subsequently, we have watched erythroblastic kine-
tics carefully prior to definite diagnosis of leukemia. The fact that pernicious
anemia and sideroblastic anemia are representative diseases with type III
sideroblast dominance and one of three cases with type III sideroblast domi-
nance became AML seems to have important implications for the preleukemic
state.
On the other hand, in AML no such characteristic pattern is observed as
in HA nor any significant difference in the incidence of different types of
sideroblast. Thus, it may be difficult to pick up atypical cases in AML on
the basis of sideroblastograms. We, however, want to draw attention to the
fact that three of five cases with type III sideroblast dominant cases turned
out to be of low percentage leukemia, and that one of these three cases was, in
the early stage, considered to belong to the preleukemic stage exhibiting in-
completely ringed sideroblasts and, in the terminal stage, showed erythro-
leukemia. As pointed out, leukemia with a hypoplastic preleukemic stage is
a pathologic state that is potentially leukemic and is essentially different from
HA; from a hematological viewpoint we have also pointed out the relationship
between leukemia with a hypoplastic prelekemic stage and atypical types of
leukemia (hypoplastic leukemia and low percentage leukemia). An increase in
type III sideroblasts may be significant with regard to the erythroblastic series
in both diseases, i. e. leukemia and HA; this demands many more cases to be
studied. Changes in the sideroblastogram of Case 5 (low percentage leukemia
followed by erythroleukemia) are presented in Fig. 6. Ringed sideroblasts,
unlike non-ringed, are believed to be due to disturbed ALA and heme synthe-
tases (9), and are characterisric for sideroblastic anemia. Ringed sideroblasts,
however, have been also observed in erythremia and erythroleukemia indicating
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relationship between the tumorous proliferation of erythroblasts and disturbed
heme synthesis (10). Such cases are extremely rare, and many provide useful
informations for the study on the relationship between sideroblastic anemia, Di
Guglielmo syndrome and leukemia.
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